Non-communicable Diseases and Occupational Health

HUMAN provides a very broad portfolio of diagnostic solutions for the assessment of Autoimmune diseases. Especially in resource limited settings with restricted access to highly trained personnel the employment of specific Line Immuno Assays reveal reliable diagnosis without performing Immuno Fluorescence Techniques (IFT). For more information on HUMAN Autoimmune Diagnostics solutions follow thislink.

Rapid tests

For the detection of prostate specific antigen (PSA)

ELISA

For cancer monitoring

CLIA

For cancer monitoring

Urine test strips

For the detection of renal micro-vascular protein leakage (Albumine to Creatinine ratio) in conjunction with the semi-automatic Combilyzer13 reader

Rapid test

Description: For the qualitative detection of Troponin I after suspected myocardial damage

Assessment of risk and/or extend of cardiovascular diseases 

Even in remote areas or regions with minimal infrastructure in combination with clinical chemistry analyzer HumaLyzer 4000with solar charge and rechargeable battery HumaPower (accessories)

HUMAN provides an unprecedented variety of diagnostic solutions for diabetes care: Diagnosis, monitoring and assessment of compliance as well as long-term sequelae.

Urine test strips

For the detection of glucose in urine or the detection of renal micro-vascular protein leakage (Albumine to Creatinine ratio)

Point of Care

For the determination of blood glucose levels and/or parameters of metabolic syndrome 

Point of Care

For the determination of HbA1c for diagnostic, monitoring and compliance assessment purposes

HPLC system

For the determination of HbA1c for diagnostic, monitoring and compliance assessment purposes

Testing for basic and/or comprehensive metabolic pane

Even in remote areas or regions with minimal infrastructure

HUMAN clinical chemistry reagents:

Enzymatic Electrolytes:

Measurement of electrolytes 

via ISE

Blood count testing

Assessment of full 3-part CBC(complete blood count) even in remote areas or regions with minimal infrastructure

3-part diff systems HumaCount 30TS and HumaCount 80TS in combination with solar charge and rechargeable battery HumaPower (accessories)

Blood count testing

Assessment of full 5-part CBC(complete blood count) with one drop of capillary or venous blood

Routine panel of screening parameters for diagnostic assessment of blood disorders related to coagulation and fibrinolysis. These assays are being performed to determine the risk of exceeded bleeding (like childbirth or surgery) as well as to determine levels after heart attack.

Clot assessment

For determination of prothrombin time (PT) by investigation of the extrinsic pathway

Clot assessment

For determination of the activated partial thromboplastin time (aPTT) by investigation of the intrinsic pathway

Clot assessment

For determination of the thrombin time (TT) for the basic screening profile

Clot assessment

For determination of fibrin clot formation (Clauss Method) to identify fibrinogen defects

Turbidimetric assay

For immunologic determination of D-dimer for exclusion of deep vein thrombosis of the leg or pulmonary embolism